Mutation of Large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy

Biochimica et Biophysica Acta - General Subjects

Volumn 1573, Issue 3, 2002, Pages 216-224

  Grewal, Prabhjit K ^a   Hewitt, Jane E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Carbohydrate; Dystroglycan; Glycosyltransferase; Mouse mutant; Muscular dystrophy

Indexed keywords

DYSTROGLYCAN; GLYCOSYLTRANSFERASE; MEMBRANE PROTEIN;

ALPHA CHAIN; AUTOSOMAL DISORDER; CATALYSIS; DISEASE COURSE; DISEASE SEVERITY; GENE; GENE DELETION; GENE MUTATION; GLYCOSYLATION; HOMOZYGOSITY; HUMAN; IMMUNOBLOTTING; INHERITANCE; LARGE GENE; MUSCLE FIBER MEMBRANE; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; CYTOSKELETAL PROTEINS; DYSTROGLYCANS; GLYCOSYLATION; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED MDX; MOLECULAR SEQUENCE DATA; MUSCULAR DYSTROPHIES; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASM PROTEINS; PHENOTYPE;

ANIMALIA;

EID: 0037137485     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(02)00387-2     Document Type: Review

References (65)

1. Hagen F.K., Nehrke K. cDNA cloning and expression of a family of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase sequence homologs from Caenorhabditis elegans. J. Biol. Chem. 273:1998;8268-8277.
2. Chen S., Zhou S., Sarker M., Spence A.M., Schachter H. Expression of three Caenorhabditis elegans N-acetylglucosaminyltransferase I genes during development. J. Biol. Chem. 274:1999;288-297.
3. Campbell K.P., Allamand V. Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum. Mol. Genet. 9:2000;2459-2467.
4. Mathews K.D., Mills K.A., Bailey H., Schelper R., Murray J. Mouse myodystrophy (myd) mutation: refined mapping in an interval flanked by homology with distal human 4q. Muscle Nerve. 2:1995;S98-S102. (Supplement).
5. Mills K.A., Mathews K.D., Scherpbier-Heddema T., Schleper R.L., Schmalzel R., Bailey H.L., Nadeau J.H., Beutow K.H., Murray J.C. Genetic mapping near the myd locus on mouse chromosome 8. Mamm. Genome. 6:1995;278-280.
6. Mills K.A., Sunada Y., Campbell K.P., Mathews K.D. A syntrophin gene maps to mouse chromosome 8 and is not the myodystrophy gene. Mamm. Genome. 6:1995;664-665.
7. Mills K.A., Ellison J.W., Mathews K.D. The Ant1 gene maps near Klk3 on proximal mouse chromosome 8. Mamm. Genome. 7:1996;707.
8. Mills K.A., Mathews K.D., Scherpbier-Heddema T., Buetow K.H., Baldini A., Ballabio A., Borsani G. Genetic and physical mapping of a voltage-dependent chloride channel gene to human 4q32 and to mouse 8. Genomics. 36:1996;374-376.
9. Mills K.A., Tresnak J., Mathews K.D. Physical mapping and sequence analysis of the myd critical region, the presumptive homolog of FSHD. Am. J. Hum. Genet. 59:1996;A308.
10. Grewal P.K., van Deutekom J.C.T., Mills K.A., Lemmers J.L.F., Mathews K.D., Frants R.R., Hewitt J.E. The mouse homolog of FRG1, a candidate gene for FSHD, maps proximal to the myodystrophy mutation on chromosome 8. Mamm. Genome. 8:1997;394-398.
11. Grewal P.K., Bolland D.J., Carim Todd L., Hewitt J.E. High resolution mapping of mouse chromosome 8 identifies an evolutionary chromosomal breakpoint. Mamm. Genome. 9:1998;603-607.
12. Dunham I., Shimizu N., Roe B.A., Chissoe S., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A., Bagguley C., Bailey J., Barlow K., Bates K.N., Beasley O., Bird C.P., Blakey S., Bridgeman A.M., Buck D., Burgess J., Burrill W.D., O'Brien K.P. The DNA sequence of human chromosome 22. Nature. 402:1999;489-495.
13. Dehal P., Predki P., Olsen A.S., Kobayashi A., Folta P., Lucas S., Land M., Terry A., Ecale Zhou C.L., Rash S., Zhang Q., Gordon L., Kim J., Elkin C., Pollard M.J., Richardson P., Rokhsar D., Uberbacher E., Hawkins T., Branscomb E., Stubbs L. Human chromosome 19 and related regions in mouse: conservative and lineage-specific evolution. Science. 293:2001;104-111.
14. Peyrard M., Seroussi E., Sandberg-Nordqvist A.-C., Xie Y.-G., Han F.-Y., Fransson I., Collins J., Dunham I., Kost-Alimova M., Imreh S. The human LARGE gene from 22q12.3-q13.1 is a new distinct member of the glycosyltransferase gene family. Proc. Natl. Acad. Sci. U. S. A. 96:1999;598-603.
15. Grewal P.K., Holzfeind P.J., Bittner R.E., Hewitt J.E. Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nat. Genet. 28:2001;151-154.
16. Heinrichs D.E., Yethon J.A., Whitfield C. Molecular basis for structural diversity in the core region of the lipopolysaccharides of Escherichia coli and Salmonella enterica. Mol. Microbiol. 30:1998;221-232.
17. Sasaki K., Kurata-Miura K., Ujita M., Angata K., Nakagawa S., Sekine S., Nishi T., Fukuda M. Expression cloning of cDNA encoding a human β-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis. Proc. Natl. Acad. Sci. U. S. A. 94:1997;14292-14299.
18. Lane P.W., Beamer T.C., Myers D.D. Myodystrophy, a new myopathy on chromosome 8 of the mouse. J. Heredity. 67:1976;135-138.
19. Mathews K.D., Rapisarda D., Bailey H.L., Murray J.C., Schleper R.L., Smith R. Phenotypic and pathological evaluation of the myd mouse, a candidate model for facioscapulohumeral dystrophy. J. Neuropathol. Exp. Neurol. 54:1995;601-606.
20. Nutting D.F., MacPike A.D., Meier H. The calcium content of various tissues from myodystrophic and dystrophic mice. J. Heredity. 71:1980;15-18.
21. Rayburn H.B., Peterson A.C. Naked axons in myodystrophic mice. Brain Res. 146:1978;380-384.
22. 2J mice. Hum. Mol. Genet. 4:1994;1055-1061.
23. Durbeej M., Henry M.D., Campbell K.P. Dystrolycan in development and disease. Curr. Opin. Cell Biol. 10:1998;594-601.
24. Holt K.H., Campbell K.P. Assembly of the sarcoglycan complex. J. Biol. Chem. 273:1998;34667-34670.
25. Holt K.H., Crosbie R.H., Venzke D.P., Campbell K.P. Biosynthesis of dystroglycan: processing of a precursor propeptide. FEBS Lett. 468:2000;79-83.
26. Ervasti J.M., Campbell K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell. 66:1991;1121-1131.
27. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 355:1992;696-702.
28. Williamson R.A., Henry M.D., Daniels K.J., Hrstka R.F., Lee C.J., Sunada Y., Ibraghimov-Beskrovnaya O., Campbell K.P. Dystroglycan is essential for early embryonic development: disruption of Reichart's membrane in Dag1-null mice. Hum. Mol. Genet. 6:1997;831-841.
29. Ervasti J.M., Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122:1993;809-823.
30. Sugiyama J., Bowen D.C., Hall Z.W. Dystroglycan binds nerve and muscle actin. Neuron. 13:1994;103-115.
31. Smalheiser N.R., Kim E. Purification of cranin, a laminin binding membrane protein. J. Biol. Chem. 270:1995;15425-15433.
32. Smalheiser N.R., Haslam S.M., Sutton-Smith M., Morris H.R., Dell A. Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain. J. Biol. Chem. 273:1998;23698-23703.
33. Brown S.C., Fassati A., Popplewell L., Page A.M., Henry M.D., Campbell K.P., Dickson G. Dystrophic phenotype induced by antibody blockade of muscle α-dystroglycan-laminin interaction. J. Cell Sci. 112:1999;209-216.
34. Côté P.D., Moukhles H., Lindebaum M., Carbonetto S. Chimeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat. Genet. 23:1999;338-342.
35. Talts J., Andac Z., Göhring W., Brancaccio A., Timpl R. Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins. EMBO J. 18:1999;863-870.
36. Chiba A.K., Matsumura H., Yamada T., Inazu T., Shimizu S., Kusunoki I., Kanazawa A., Kobata A., Endo T. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve a-dystroglycan. J. Biol. Chem. 272:1997.
37. Ervasti J.M., Burwell A.L., Geissler A.L. Tissue-specific heterogeneity in α-dystroglycan sialoglycosylation. J. Biol. Chem. 272:1997;22315-22321.
38. Henry M.D., Campbell K.P. A role for dystroglycan in basement membrane assembly. Cell. 95:1998;859-870.
39. Henry M.D., Campbell K.P. Dystroglycan inside and out. Curr. Opin. Cell Biol. 11:1999;602-607.
40. Bowe M., Deyst K., Leszyk J., Fallon J. Identification and purification of an agrin receptor from torpedo postsynaptic membranes: a heteromeric complex related to the dystroglycans. Neuron. 12:1994;1173-1180.
41. Campanelli J., Roberds S., Campbell K., Scheller R. A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AchR clustering. Cell. 77:1994;663-674.
42. Gee S.H., Montanaro F., Lindenbaum M.H., Carbonetto S. Dystroglycan-α, a dystrophin associated glycoprotein, is a functional agrin receptor. Cell. 77:1994;675-686.
43. Peng H.B., Ali A.A., Daggett D.F., Rauvala H., Hassell J.R., Smalheiser N.R. The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhes. Commun. 5:1998;475-489.
44. Sugita S., Saito F., Tang J., Satz J., Campbell K., Südhof T.C. A stoichiometric complex of neurexins and dystroglycan in brain. J. Cell Biol. 154:2001;435-445.
45. Winder S.J. The complexities of dystroglycan. Trends Biochem. Sci. 26:2001;118-124.
46. Cao W., Henry M.D., Borrow P., Yamada H., Elder J.H., Ravkov E.V., Nichol S.T., Compans R.W., Campbell K.P., Oldstone M.B.A. Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science. 282:1998;2079-2081.
47. Rambukkama A., Yamada H., Zanazzi G., Mathus T., Salzer J.L., Yurchenco P.D., Campbell K.P., Fischetti V.A. Role of a-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science. 282:1998;2076-2079.
48. Rambukkama A. Molecular basis for the peripheral nerve predilection of Mycobacterium leprae. Curr. Opin. Microbiol. 4:2001;21-27.
49. Xu H., Wu X.-R., Wewer U.M., Engvall E. Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene. Nat. Genet. 8:1994;297-301.
50. Muntoni F., Sewry C.A. Congenital muscular dystrophy: from rags to riches. Neurology. 51:1998;14-16.
51. Campbell K.P. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix lineage. Cell. 80:1995;675-679.
52. Durbeej M., Larsson E., Ibraghimov-Beskrovnaya O., Roberds S.L., Campbell K.P., Ekblom P. Non-muscle α-dystroglycan is involved in epithelial development. J. Cell Biol. 130:1995;79-91.
53. Breton C., Imberty A. Structure/function studies of glycosyltransferases. Curr. Opin. Struct. Biol. 9:1999;563-571.
54. Wijmenga C., Hewitt J.E., Sandkuijl L.A., Clark L.N., Wright T.J., Dauwerse H.G., Gruter A.-M., Hofker M.H., Moerer P., Williamson R., van Ommen G.-J.B., Padberg G.W., Frants R.R. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat. Genet. 2:1992;26-30.
55. Kobayashi K., Nakahori Y., Miyake M., Matsumura K., Kondo-Iida E., Nomura Y., Segawa M., Yoshioka M., Saito K., Osawa M., Hamano K., Sakakihara Y., Nonaka I., Nakagome Y., Kanazawa I., Nakamura Y., Tokunaga K., Toda T. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature. 394:1998;388-392.
56. Aravind L., Koonin E.V. The fukutin protein family - predicted enzymes modifying cell-surface molecules. Curr. Biol. 9:1999;R836-R837.
57. Hayashi Y.K., Ogawa M., Tagawa K., Noguchi S., Ishihara T., Nonaka I., Arahata K. Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology. 57:2001;115-121.
58. Brockington M., Blake D.J., Prandini P., Brown S.C., Torelli S., Benson M.A., Ponting C.P., Estournet B., Romero N.B., Mercuri E., Voit T., Sewry C.A., Guicheney P., Muntoni F. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am. J. Hum. Genet. 69:2001;1198-1209.
59. Brockington M., Yuva Y., Prandini P., Brown S.C., Torelli S., Benson M.A., Herrmann R., Anderson L.V.B., Bashir R., Burgunder J.-M., Fallet S., Romero N., Fardeau M., Straub V., Storey G., Pollitt C., Richard I., Sewry C.A., Bushby K., Voit T., Blake D.J., Muntoni F. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum. Mol. Genet. 10:2001;2851-2859.
60. Yoshida A., Kobayasi K., Manya H., Taniguchi K., Kano H., Mizuno M., Inazu T., Mitsuhashi H., Takahashi S., Takeuchi M., Herrmann R., Straub V., Talim B., Voit T., Topaloglu H., Toda T., Endo T. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase POMGnT1. Dev. Cell. 1:2001;717-724.
61. Zhang W., Betel D., Schachter H. Cloning and expression of a novel UDP-GlcNAc:α-D-mannoside β1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:α-3-D-mannoside β1,2-N-acetylglucosaminylransferase I. Biochem. J. 361:2001;153-162.
62. Dell A., Morris H.R. Glycoprotein structure determination by mass spectrometry. Science. 291:2001;2351-2356.
63. Chui D., Sellakumar G., Green R.S., Sutton-Smith M., McQuistan T., Marek K.W., Morris H.R., Dell A., Marth J.D. Genetic remodelling of protein glycosylation in vivo induces autoimmune disease. Proc. Natl. Acad. Sci. U. S. A. 98:2001;1142-1147.
64. Gieseler K., Abdel-Dayem M., Ségalat L. In vitro interactions of Caenorhabditis elegans dystrophin with dystrobrevin and syntrophin. FEBS Lett. 461:1999;59-62.
65. Giugia J.-B., Giesler K., Arpagaus M., Ségalat L. Mutations in the dystrophin-like dys-1 gene of Caenorhabditis elegans result in reduced acetylcholinesterase activity. FEBS Lett. 463:1999;270-272.